Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. CME Group (CME) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.CME Group is one of 858 individual stocks in the Finance sector. Collectively, these companies sit at #6 in ...

Group 1 - CME Group announced preliminary shareholder voting results from its 2025 annual meeting, indicating no quorum in the elections for Class B directors, leading to the continuation of incumbent directors until the 2026 annual meeting [1] - The company elected several directors for a one-year term expiring in 2026, including Terrence A. Duffy and Kathryn Benesh among others [4] - Ernst & Young LLP was ratified as the independent registered public accounting firm for 2025, and the compensation of named executive officers was approved on an advisory basis [4] Group 2 - CME Group operates as a leading derivatives marketplace, facilitating trading in futures, options, cash, and OTC markets, and providing tools for risk management and opportunity capture [2] - The company offers a wide range of global benchmark products across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals [2] - CME Group's trading platforms include CME Globex for futures and options, BrokerTec for fixed income, and EBS for foreign exchange [2]

CME Group (CME) hit a 52-week high of $286.48 on May 7. Shares closed at $284.82 after gaining 22% year to date, outperforming the industry, the sector and the Zacks S&P 500 composite in the same time frame.CME Group has outperformed its peers, Cboe Global Markets (CBOE) and Intercontinental Exchange Inc. (ICE) , which have gained 19.9% and 18.5%, respectively, year to date.With a capitalization of $102.6 billion, CME Group is the largest futures exchange in the world in terms of trading volume and notional ...

CME Group (CME) FY 2025 Annual General Meeting May 08, 2025 11:00 AM ET Speaker0 Everyone, we'll go ahead and get started. I want to thank all of you for joining us this morning. It's my pleasure to welcome you to the twenty twenty five CME Group Annual Meeting of Shareholders. I'm Terry Duffy, the chairman and chief executive officer of CME Group. Seated next to me is our president and chief financial officer, miss Lynn Fitzpatrick, and to her right is our Corporate Secretary, Meg Wright, who Lynn will be ...

Interest rate ADV grew 46% to 18.4 million contracts Record monthly ADV in equity index and metals products Record monthly international ADV of 10.9 million contractsCHICAGO, May 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its April 2025 market statistics reached an all-time monthly average daily volume (ADV) record of 35.9 million contracts, an increase of 36% year-over-year.The company's interest rate ADV grew 46% to 18.4 million contracts in April, whil ...

The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. CME Group (CME) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Finance sector should help us answer this question.CME Group is a member of the Finance sector. This group includes 858 individual st ...

Group 1 - CME Group is initiated with a Strong Buy rating and a price target of $332.96, highlighting its position as a global leader in futures and options trading [1] - The company operates in an institutionalized arena where trillions in futures and options are traded, routed, and cleared daily, emphasizing its critical role in the financial markets [1] - Moretus Research focuses on identifying companies with durable business models and mispriced cash flow potential, applying a structured framework for investment analysis [1] Group 2 - Moretus Research combines rigorous fundamental analysis with a judgment-driven process, aiming to provide clarity and actionable insights for serious investors [1] - The research emphasizes comparability, simplicity, and relevance in valuation, tailored to each company's business model and capital structure [1] - The coverage tends to favor underappreciated companies undergoing structural changes or temporary dislocations, where disciplined analysis can lead to asymmetric returns [1]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: CME Group - CME Group currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, CME shares increased by 1.44%, while the Zacks Securities and Exchanges industry rose by 2.89% [5] - In a longer timeframe, CME shares have appreciated by 12.3% over the past quarter and 29.92% over the last year, outperforming the S&P 500, which saw declines of -7.64% and gains of 10.16% respectively [6] Trading Volume - CME's average 20-day trading volume is 2,997,252 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, 10 earnings estimates for CME have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $10.53 to $11.11 [9] - For the next fiscal year, 9 estimates have moved higher, while 1 has been revised downwards [9] Conclusion - Considering the positive price trends, strong earnings outlook, and favorable momentum score, CME Group is identified as a solid momentum pick for investors [11]

I'm a passionate investor from the Netherlands with 12 years of stock market experience. My articles usually contain a good overview of important investment criteria. A stock for my portfolio is of interest to me if the company has the following characteristics:1. Companies that are growing in both revenue, earnings and free cash flow.2. Companies that have excellent growth prospects.3. Stocks with favorable valuations.I prefer steadily growing companies with high free cash flow margins, dividend stocks and ...